Ripretinib as a second-line therapy for advanced gastrointestinal stromal tumors in the era of precision medicine
@article{ACTR9420, author = {Toshirou Nishida and Osakuni Morimoto and Yoshihito Ide}, title = {Ripretinib as a second-line therapy for advanced gastrointestinal stromal tumors in the era of precision medicine}, journal = {AME Clinical Trials Review}, volume = {2}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/9420} }